Skip to main content
PMC home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1990 Mar;136(3):623–630.

Pentoxifylline-induced modulation of human leukocyte function in vitro.

K Josaki 1, J Contrino 1, J Kristie 1, P Krause 1, D L Kreutzer 1
PMCID: PMC1877473  PMID: 2316627

Abstract

We previously demonstrated that pentoxifylline stimulated leukocyte migration in vitro and leukocyte accumulation in vivo and protects neonatal mice from experimentally induced Staphylococcus aureus infections. In the present studies we have investigated pentoxifylline's effect on human leukocyte function in vitro. In these studies we demonstrate that pentoxifylline at low concentrations (ie, 0.01 and 0.1 mg/ml) stimulates both leukocyte migration and microbicidal activity in vitro. Alternatively, low concentrations (0.001 to 0.1 mg/ml) of pentoxifylline had no significant effect on the binding uptake of S. aureus by leukocytes, nor did it enhance phagocytic degranulation. At extremely low concentrations (0.001 mg/ml), pentoxifylline enhanced oxygen metabolism by human leukocytes, as reflected by increased H2O2 production and chemiluminescence (CL). At higher concentrations (ie, 0.1 to 1 mg/ml), pentoxifylline consistently suppressed these leukocyte functions in vitro. Thus, this study supports the following hypothesis: 1) the in vivo effects of pentoxifylline may involve a direct effect on both leukocyte mobilization and microbicidal activity, and 2) the enhanced microbicidal activity induced by pentoxifylline may be a result of enhanced leukocyte oxygen metabolism. In summary, pentoxifylline appears to be an interesting immunomodulator (ie, immunoenhancement and immunosuppression) of leukocyte function in vitro, but additional studies will be required before the efficacy of pentoxifylline in man can be determined.

Full text

PDF
623

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson D. C., Hughes B. J., Smith C. W. Abnormal mobility of neonatal polymorphonuclear leukocytes. Relationship to impaired redistribution of surface adhesion sites by chemotactic factor or colchicine. J Clin Invest. 1981 Oct;68(4):863–874. doi: 10.1172/JCI110341. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bessler H., Gilgal R., Djaldetti M., Zahavi I. Effect of pentoxifylline on the phagocytic activity, cAMP levels, and superoxide anion production by monocytes and polymorphonuclear cells. J Leukoc Biol. 1986 Dec;40(6):747–754. doi: 10.1002/jlb.40.6.747. [DOI] [PubMed] [Google Scholar]
  3. Bortolussi R., Fischer G. W. Opsonic and protective activity of immunoglobulin, modified immunoglobulin, and serum against neonatal Escherichia coli K1 infection. Pediatr Res. 1986 Feb;20(2):175–178. doi: 10.1203/00006450-198602000-00017. [DOI] [PubMed] [Google Scholar]
  4. Cairo M. S., Rucker R., Bennetts G. A., Hicks D., Worcester C., Amlie R., Johnson S., Katz J. Improved survival of newborns receiving leukocyte transfusions for sepsis. Pediatrics. 1984 Nov;74(5):887–892. [PubMed] [Google Scholar]
  5. Christensen R. D., Rothstein G., Anstall H. B., Bybee B. Granulocyte transfusions in neonates with bacterial infection, neutropenia, and depletion of mature marrow neutrophils. Pediatrics. 1982 Jul;70(1):1–6. [PubMed] [Google Scholar]
  6. Edwards M. S., Buffone G. J., Fuselier P. A., Weeks J. L., Baker C. J. Deficient classical complement pathway activity in newborn sera. Pediatr Res. 1983 Aug;17(8):685–688. doi: 10.1203/00006450-198308000-00017. [DOI] [PubMed] [Google Scholar]
  7. Hill H. R., Augustine N. H., Newton J. A., Shigeoka A. O., Morris E., Sacchi F. Correction of a developmental defect in neutrophil activation and movement. Am J Pathol. 1987 Aug;128(2):307–314. [PMC free article] [PubMed] [Google Scholar]
  8. Krause P. J., Herson V. C., Boutin-Lebowitz J., Eisenfeld L., Block C., LoBello T., Maderazo E. G. Polymorphonuclear leukocyte adherence and chemotaxis in stressed and healthy neonates. Pediatr Res. 1986 Apr;20(4):296–300. doi: 10.1203/00006450-198604000-00004. [DOI] [PubMed] [Google Scholar]
  9. Krause P. J., Herson V. C., Eisenfeld L., Johnson G. M. Enhancement of neutrophil function for treatment of neonatal infections. Pediatr Infect Dis J. 1989 Jun;8(6):382–389. doi: 10.1097/00006454-198906000-00011. [DOI] [PubMed] [Google Scholar]
  10. Krause P. J., Kristie J., Wang W. P., Eisenfeld L., Herson V. C., Maderazo E. G., Jozaki K., Kreutzer D. L. Pentoxifylline enhancement of defective neutrophil function and host defense in neonatal mice. Am J Pathol. 1987 Nov;129(2):217–222. [PMC free article] [PubMed] [Google Scholar]
  11. Kreutzer D. L., O'Flaherty J. T., Orr W., Showell H. J., Ward P. A., Becker E. L. Quantitative comparisons of various biological responses of neutrophils to different active and inactive chemotactic factors. Immunopharmacology. 1978 Dec;1(1):39–47. doi: 10.1016/0162-3109(78)90007-3. [DOI] [PubMed] [Google Scholar]
  12. Laurenti F., Ferro R., Isacchi G., Panero A., Savignoni P. G., Malagnino F., Palermo D., Mandelli F., Bucci G. Polymorphonuclear leukocyte transfusion for the treatment of sepsis in the newborn infant. J Pediatr. 1981 Jan;98(1):118–123. doi: 10.1016/s0022-3476(81)80556-2. [DOI] [PubMed] [Google Scholar]
  13. Miller M. E. Phagocytosis in the newborn infant: humoral and cellular factors. J Pediatr. 1969 Feb;74(2):255–259. doi: 10.1016/s0022-3476(69)80073-9. [DOI] [PubMed] [Google Scholar]
  14. Pick E., Keisari Y. A simple colorimetric method for the measurement of hydrogen peroxide produced by cells in culture. J Immunol Methods. 1980;38(1-2):161–170. doi: 10.1016/0022-1759(80)90340-3. [DOI] [PubMed] [Google Scholar]
  15. Shigeoka A. O., Pincus S. H., Rote N. S., Hill H. R. Protective efficacy of hybridoma type-specific antibody against experimental infection with group-B Streptococcus. J Infect Dis. 1984 Mar;149(3):363–372. doi: 10.1093/infdis/149.3.363. [DOI] [PubMed] [Google Scholar]
  16. Strauss R. G., Connett J. E., Gale R. P., Bloomfield C. D., Herzig G. P., McCullough J., Maguire L. C., Winston D. J., Ho W., Stump D. C. A controlled trial of prophylactic granulocyte transfusions during initial induction chemotherapy for acute myelogenous leukemia. N Engl J Med. 1981 Sep 10;305(11):597–603. doi: 10.1056/NEJM198109103051101. [DOI] [PubMed] [Google Scholar]
  17. Strieter R. M., Remick D. G., Ward P. A., Spengler R. N., Lynch J. P., 3rd, Larrick J., Kunkel S. L. Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxifylline. Biochem Biophys Res Commun. 1988 Sep 30;155(3):1230–1236. doi: 10.1016/s0006-291x(88)81271-3. [DOI] [PubMed] [Google Scholar]
  18. Sullivan G. W., Carper H. T., Novick W. J., Jr, Mandell G. L. Inhibition of the inflammatory action of interleukin-1 and tumor necrosis factor (alpha) on neutrophil function by pentoxifylline. Infect Immun. 1988 Jul;56(7):1722–1729. doi: 10.1128/iai.56.7.1722-1729.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Winston D. J., Ho W. G., Howell C. L., Miller M. J., Mickey R., Martin W. J., Lin C. H., Gale R. P. Cytomegalovirus infections associated with leukocyte transfusions. Ann Intern Med. 1980 Nov;93(5):671–675. doi: 10.7326/0003-4819-93-5-671. [DOI] [PubMed] [Google Scholar]
  20. Wright D. G., Robichaud K. J., Pizzo P. A., Deisseroth A. B. Lethal pulmonary reactions associated with the combined use of amphotericin B and leukocyte transfusions. N Engl J Med. 1981 May 14;304(20):1185–1189. doi: 10.1056/NEJM198105143042001. [DOI] [PubMed] [Google Scholar]
  21. Wright W. C., Jr, Ank B. J., Herbert J., Stiehm E. R. Decreased bactericidal activity of leukocytes of stressed newborn infants. Pediatrics. 1975 Oct;56(4):579–584. [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES